IMMUNITYBIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.87 USD | +4.82% |
|
-3.61% | +16.93% |
| 05-09 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-07 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUNITYBIO, INC. | Bio Therapeutic Drugs | +4.82% | -3.61% | +16.93% | +96.32% | - | 3.87B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IBRX Stock
- Charts ImmunityBio, Inc.
- Comparison Chart
